Literature DB >> 2723766

High-affinity uptake of L-kynurenine by a Na+-independent transporter of neutral amino acids in astrocytes.

C Speciale1, K Hares, R Schwarcz, N Brookes.   

Abstract

L-Kynurenine (KYN), an intermediary product in the kynurenine pathway of tryptophan metabolism, is the common precursor from which are formed both quinolinic acid, a potent endogenous "excitotoxin," and kynurenic acid, a nonselective antagonist of excitotoxins. The present work examines 3H-KYN transport in primary astrocyte cultures derived from the cerebra of newborn mice. Influx and efflux of 3H-KYN were attributable almost entirely to carrier-mediated transport. The tritium recovered in uptake experiments was identifiable as 3H-KYN, indicating a low rate of KYN metabolism during incubations up to 30 min. KYN uptake decreased in the presence of extracellular Na+, at least in part because KYN efflux was accelerated. Marked trans stimulation of KYN efflux by extracellular KYN provided evidence of the exchanging nature of the carrier. Saturation curves for the initial velocity of KYN uptake conformed to a 1-component saturable system with Km of 32 microM and Vmax of 2.1 nmol mg-1 protein min-1. KYN was notably concentrated by the astrocytes, with an estimated steady-state distribution ratio of 180-fold for 1 microM KYN. Analog inhibition studies showed that the KYN transporter exhibited a clear preference for large neutral amino acids; leucine, tryptophan, and phenylalanine were recognized with relatively higher affinity than KYN. In summary, KYN is concentratively transported into astrocytes by a Na+-independent exchanger with high affinity for branched-chain and aromatic neutral amino acids. The substrate specificity and high affinity of this transport system resemble the properties of neutral amino acid transport across the blood-brain barrier in the rat and human.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2723766      PMCID: PMC6569713     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  26 in total

1.  Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine.

Authors:  Kathleen S Alexander; Hui-Qiu Wu; Robert Schwarcz; John P Bruno
Journal:  Psychopharmacology (Berl)       Date:  2011-10-26       Impact factor: 4.530

2.  Model of tryptophan metabolism, readily scalable using tissue-specific gene expression data.

Authors:  Anne-Kristin Stavrum; Ines Heiland; Stefan Schuster; Pål Puntervoll; Mathias Ziegler
Journal:  J Biol Chem       Date:  2013-10-15       Impact factor: 5.157

Review 3.  Kynurenic acid as an antagonist of α7 nicotinic acetylcholine receptors in the brain: facts and challenges.

Authors:  Edson X Albuquerque; Robert Schwarcz
Journal:  Biochem Pharmacol       Date:  2012-12-25       Impact factor: 5.858

4.  Expression of the surface antigen 4F2hc affects system-L-like neutral-amino-acid-transport activity in mammalian cells.

Authors:  S Bröer; A Bröer; B Hamprecht
Journal:  Biochem J       Date:  1997-06-01       Impact factor: 3.857

5.  The role of hydrogen peroxide in the in vitro cytotoxicity of 3-hydroxykynurenine.

Authors:  C L Eastman; T R Guilarte
Journal:  Neurochem Res       Date:  1990-11       Impact factor: 3.996

Review 6.  Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders.

Authors:  Sophie Erhardt; Sara K Olsson; Göran Engberg
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

7.  Induction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behavior.

Authors:  Jason C O'Connor; Marcus A Lawson; Caroline André; Eileen M Briley; Sandra S Szegedi; Jacques Lestage; Nathalie Castanon; Miles Herkenham; Robert Dantzer; Keith W Kelley
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

8.  Kynurenine Signaling Increases DNA Polymerase Kappa Expression and Promotes Genomic Instability in Glioblastoma Cells.

Authors:  April C L Bostian; Leena Maddukuri; Megan R Reed; Tatsiana Savenka; Jessica H Hartman; Lauren Davis; Dakota L Pouncey; Grover P Miller; Robert L Eoff
Journal:  Chem Res Toxicol       Date:  2015-12-30       Impact factor: 3.739

9.  On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo.

Authors:  Laura Amori; Paolo Guidetti; Roberto Pellicciari; Yasushi Kajii; Robert Schwarcz
Journal:  J Neurochem       Date:  2009-02-06       Impact factor: 5.372

10.  The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression.

Authors:  Marieke C Wichers; Michael Maes
Journal:  J Psychiatry Neurosci       Date:  2004-01       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.